Farmers and growers have been using glyphosate-based herbicides safely and effectively to control weeds for more than 40 years. These products continue to play a critical role in helping farmers manage weeds and sustainably deliver crops to markets around the world.
In 2015, after the International Agency for Research on Cancer (IARC) classified glyphosate as a “probable carcinogen,” trial attorneys in the U.S. began running advertisements to recruit plaintiffs for lawsuits against Monsanto, the manufacturer of many glyphosate-based herbicides (i.e., Roundup®-branded herbicides). These lawsuits rely heavily on IARC’s classification, which runs counter to an extensive body of science supporting glyphosate’s safe use and has many significant limitations and flaws.
A number of trials are currently scheduled for 2019 in several venues, including the federal MDL in the District Court for the Northern District of California, state court in California, state courts in both St. Louis City and St. Louis County, Missouri, and a state court in Montana. The next trial is currently scheduled to take place in state court in St. Louis County on August 19, 2019. Please note that trial schedules are subject to change based on the schedules of the courts and parties.
- Adams (St. Louis County, Missouri): August 19, 2019
- Lamb (St. Louis County, Missouri): September 9, 2019
- Winston (St. Louis City, Missouri): October 15, 2019
- Cazier (Gallatin County, Montana District Court): October 21, 2019
Bayer will vigorously defend its products based on the strong body of science that confirms glyphosate and glyphosate-based products are safe when used as directed and that glyphosate does not cause cancer.